To investigate the mechanisms of a,-adrenergic vascular desensitization, osmotic minipumps containing either saline (n= 9) or amidephrine mesylate (AMD) (n =9), a selective a,-adrenergic receptor agonist, were implanted subcutaneously in dogs with chronically implanted arterial and right atrial pressure catheters and aortic flow probes. After chronic al-adrenergic receptor stimulation, significant physiological desensitization to acute AMD challenges was observed, i.e., pressor systems.4 The majority of these studies focused on myocardial desensitization and consequently have examined f3-adrenergic receptor mechanisms, which are the predominant catecholamine receptors for regulating myocardial contractility.5-9 In contrast, a,-adrenergic receptors are the primary catecholamine receptors regulating peripheral vascular tone.'0 Mechanisms of aladrenergic vascular desensitization have also been examined,'1-24but again under in vitro conditions." [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] 20, 21, 23, 24 The extent to which a,-adrenergic peripheral vascular desensitization occurs and the mechanisms involved in intact animals are not known. Accordingly, the overall goal of this study was to investigate the effects of chronic a,-adrenergic receptor stimulation on peripheral vascular responses in which physiological desensitization in chronically instrumented, conscious dogs could be exam-
KEY WoRDs * arl-adrenergic receptor * desensitization * catecholamine * dogs C eatecholamine desensitization has been recognized for over 30 years'-3 and has been studied extensively, primarily through the use of in vitro systems. 4 The majority of these studies focused on myocardial desensitization and consequently have examined f3-adrenergic receptor mechanisms, which are the predominant catecholamine receptors for regulating myocardial contractility.5-9 In contrast, a,-adrenergic receptors are the primary catecholamine receptors regulating peripheral vascular tone.'0 Mechanisms of aladrenergic vascular desensitization have also been examined,'1-24but again under in vitro conditions." [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] 20, 21, 23, 24 The extent to which a,-adrenergic peripheral vascular desensitization occurs and the mechanisms involved in intact animals are not known. Accordingly, the overall goal of this study was to investigate the effects of chronic a,-adrenergic receptor stimulation on peripheral vascular responses in which physiological desensitization in chronically instrumented, conscious dogs could be exam- ined and then correlated with in vitro studies. In view of recent studies demonstrating that autonomic mechanisms complicate ,3-adrenergic receptor-mediated de- sensitization in the heart,25 our underlying hypothesis was that the expression of peripheral vascular a1-adrenergic receptor desensitization, particularly to the physiological neurotransmitter norepinephrine (NE), would depend on autonomic reflex mechanisms as well as biochemical mechanisms. NE, which is the predominant a-adrenergic neurotransmitter at the nerve terminal and effector organ junction, increases arterial pressure and induces baroreflex buffering, resulting in diminished sympathetic neural tone and enhanced parasympathetic restraint. Furthermore, NE is taken up by nerves, which could affect concentrations of the a-adrenergic agonist at the postjunctional receptor site.
Accordingly, the primary goal of the present investigation was to determine whether chronic a1-adrenergic receptor 
Measurements
Hemodynamic measurements were recorded on a multichannel tape recorder (Honeywell, Denver, Colo.) and played back on a direct-writing oscillograph (Gould-Brush, Cleveland, Ohio). Fluid-filled catheters in the aorta and right atrium were connected to straingauge manometers (Statham Instruments, Oxnard, Calif.) for the measurement of arterial and right atrial pressures. A transonic flowmeter was used to measure cardiac output. The flow probes were calibrated in vitro using timed blood collections in a gravity flow system. Zero aortic flow was assumed to occur during mid and late diastole. Mean values for arterial pressure and aortic flow, i.e., cardiac output, were obtained continuously using resistance-capacitance circuits. Mean values, which are less susceptible to artifact than instantaneous values, were used to assess the data. Calculations of total peripheral resistance (TPR) were used to assess peripheral vasoconstriction. Total peripheral resistance was calculated as the quotient of mean arterial pressure (MAP) minus mean right atrial pressure and cardiac output.
Protocol
First, the a1-adrenergic selectivity of AMD was investigated. To accomplish this, acute challenges to NE (0.4 jg/kg per minute), which stimulates both al-and a2-receptors, and to AMD (4 jig/kg per minute) were examined in the conscious state in the presence of f8-adrenergic receptor blockade with propranolol (1 mg/kg). This dose of propranolol abolished the effects of isoproterenol (0.1 ,g/kg). The effects of NE or AMD were then examined in the presence of 1B-and aladrenergic receptor blockade with prazosin (1.5 mg/kg), which abolished the effects of phenylephrine (PE) (5 ,ug/kg). Baseline hemodynamics before pump implantation and at 1 day, 4 days, 1 week, 2 weeks, and 3 weeks after AMD pumps were examined. The time course of 
Membrane Preparation
At 5-7 days after the third pump implantation, the animals were anesthetized with sodium pentobarbital (30 mg/kg) and the entire aorta and mesenteric vascular tree were removed quickly for membrane preparation. The aorta and mesenteric vascular tree were placed in ice-cold buffer A (250 mM sucrose, 10 mM HEPES, 10 mM PMSF, and 10 mM benzamidine, pH 7.5). for 20 minutes. The supernatant was next centrifuged at 210,000g (Sorvall ultracentrifuge) to obtain the microsomal pellet. The microsomal pellet was resuspended in buffer B (100 mM Tris, 5 mM EGTA, 10 mM PMSF, and 10 mM benzamidine, pH 7.5) by homogenization and subsequently repelleted and rehomogenized into the same buffer to a protein concentration of 4-6 mg/ml in the aorta and 1.5 mg/ml in the mesentery before storing at -70°C. The yield of membrane protein in the aorta was 1.5 mg/g wet wt, and the yield of membrane protein in the mesentery was 0.5 mg/g wet wt. To determine whether significant material was discarded after the first 1,000g centrifugation, the pellet from the first 1,000g centrifugation was examined. transferase derived from rat liver. These derivatives are then extracted and purified by thin-layer chromatography on silica gel and converted by periodate oxidation (requiring an a-OH group) to the aromatic aldehyde, which is then extracted and counted. To determine whether AMD was measured as NE in the assay, increasing concentrations of AMD, from 1 to 1,000 ,ttg/ml, were added to samples from five normal dogs.
AMD did not affect the measurement of NE significantly.
Isolated Mesenteric Artery Studies
At the time of death, the mesenteric artery from six AMD pump dogs and six saline pump dogs was excised and placed in Krebs-Ringer bicarbonate buffer bubbled with 95% 02-5% CO2 and containing (mM) NaCl 117, KCl 5.0, NaHCO3 25.0, CaCl2 1.25, MgSO4 1.26, KH2PO4 1.0, and dextrose 10.0. While maintained at room temperature in this buffer, the adherent adventitia and fatty tissue were removed. Mesenteric artery rings 2 mm wide in the absence and presence of endothelium were mounted in a 25-ml jacketed tissue bath kept at 37.5-38°C. A basal tension was applied as described by Angus et and KCI (10-70 mM) were generated by producing a stepwise increase in concentration of each drug as soon as a steady response was obtained from each preceding dose. Relaxation elicited by acetylcholine (10-9-10-5 M) in preparations precontracted with 30 mM KCl were used to ascertain the integrity of the endothelium.
Data Analysis
Mean values and standard errors were calculated with an IBM PC/AT computer (IBM Instruments, Inc., Danbury, Conn.). The data collected from the same dogs before and after pump implantation or before and after infusion of NE, AMD, and PE were tested statistically with Student's t test for paired data, whereas the comparison between the groups with saline and AMD pumps was made by Student's t test for grouped data. 34 The relations between the doses of NE and AMD and their responsiveness were examined by regression analysis. Comparison of regression lines was performed by determining the significance of differences in both the slopes and elevations of the lines by the F test. 35 For the studies in isolated vascular rings, statistical comparison of maximal contraction between saline and AMD dogs was performed using both Student's t test for grouped data and the multigroup repeated measurements analysis of variance, whereas comparisons with and without endothelium were performed using Student's t test for paired data. A value of p<0.05 was considered statistically significant.
Results

a1-Adrenergic Selectivity ofAMD
The pressor and vasoconstrictor responses to NE were not abolished but only attenuated by a,-adrenergic receptor blockade with prazosin. In contrast, the pressor and vasoconstrictor responses to AMD were abolished by a1-adrenergic receptor blockade, indicating that AMD is a selective a,-adrenergic receptor agonist.
We selected AMD as the agonist rather than PE because the latter also possesses f3-adrenergic receptor properties.
Effects ofAMD and Saline Pumps on Baseline Hemodynamics
Mean Arterial Pressure Before ld 4d lwk 2wk 3wk tion of pumps. The saline pumps elicited no change in hemodynamics.
Increases in MAP and TPR and decreases in heart rate and cardiac output were evident at 1 day after AMD pump implantation and reached a steady state at 1 week after pump implantation (Figure 1 ). At 2-3 weeks after AMD pump implantation, MAP and TPR were significantly increased (p<O.O5) and cardiac output and heart rate were significantly decreased (p<O.O5) when compared with values observed in the dogs with saline pumps (Table 1) . Time Course of Desensitization Figure 2 shows the time course of physiological desensitization to AMD. AMD challenges induced similar increases in MAP and TPR at 1 or 4 days after pump implantation compared with responses before pump implantation, i.e., no desensitization, but at 1 week after implantation of AMD pumps, physiological desensitization to AMD was observed. Thus, despite evidence of effects of AMD on baseline values of MAP and TPR at 1 day after pump implantation, desensitization was not observed until 1 week after pump implantation.
Effects of a-Adrenergic Receptor Challenges in the Presence of (3-Adrenergic Receptor Blockade Before and After AMD Pumps Physiological desensitization was assessed by comparing a-adrenergic receptor-mediated pressor and vasoconstrictor responses, i.e., increases in MAP and TPR, before and after the AMD pumps were implanted. In the dogs studied with (Figure 3 ). In contrast, there were significant differences (p<0.01) in both the slopes and elevations of the regression lines in response to AMD before and after pumps (Figure 3 (Table 3 ). These differences were apparent at all doses studied (Figure 4 ). After pumps there was a significant difference (p<0.01) in the elevation of the regression lines in response to NE (Figure 4 ), but the slopes of the lines were not different. (Table 3 ). There were significant differences (p< 0.01) in both the slopes and elevations of the regression lines in response to NE before and after pumps ( Figure 5 ). After chronic a,-adrenergic receptor stimulation, acute AMD challenge (2 ,tg/kg per minute) in the presence of /3-adrenergic receptor, ganglionic, and NE-uptake blockade induced smaller increases (p<0.05) in MAP (10+7 versus 95±+3 mm Hg) and TPR (13.2+5.9 versus 66.3+±9.3 mm Hg/l per minute) compared with responses in the control state (Table  2 ). There were significant differences (p<0.01) in both the slopes and elevations of the regression lines in response to AMD before and after pumps ( Figure 5 ). Acute 
Responsiveness of Isolated Mesenteric Artery Rings
With intact endothelium the relaxations induced by acetylcholine were essentially identical in rings from AMD pump dogs and saline pump dogs ( Figure 6 ). In contrast, the maximal force of contraction induced by AMD was significantly decreased (p<0.05) in isolated mesenteric artery rings from the AMD pump group compared with the saline pump group (2.73±0.63 versus 5.07±0.57 g) (Figure 7) . In mesenteric artery rings without endothelium, acetylcholine induced equivalent constriction in both groups (Figure 6 ), whereas AMD still induced less (p<0.05) force of contraction in the AMD pump group compared with the saline pump group (3.56±0.41 versus 6.18±0.79 g) (Figure 7 ). In contrast, the KCl-induced contraction, which is nonspecific, i.e., not mediated by receptor stimulation, was not different between the two groups whether or not the endothelium was removed (Figure 7) . The maximal force of contraction induced by NE and PE was also reduced in isolated mesenteric artery rings in the presence of endothelium in the AMD pump group compared with the saline pump group (Figure 8 ).
These studies indicate that desensitization to acute challenges to a-adrenergic receptor agonists were a1-adrenergic receptor-specific and not dependent on the endothelium. (Table 4 ). There were no significant differences between the two groups in a2-(93+±6 versus 86+15 fmol/mg protein) and /3-adrenergic receptor densities (14±1 versus 16±2 fmol/mg protein) in the aorta. On the other hand, in membrane preparations from vessels in the mesentery, which contained intermediate-sized vessels to capillaries, a1-adrenergic receptor density was decreased (8.2±1.0 versus 18.4±1.4 fmol/mg protein, p<O.001) without any change in Kd in the AMD pump group compared with the saline pump group (Table 4) .
a-Adrenergic Receptor Analyses in Membrane Preparations
NE-Induced Displacement of [3H]Prazosin Binding in Aortic Membranes
In the three animals studied with saline pumps, the use of a model for two classes of receptor sites resulted in a significant improvement of the fit of the data, as compared with a model for a single class of receptor sites. The parameter estimates for the affinity constants were KH=4.3+0.6 ,uM and KL=130±50 ,M with proportions of 82±2% and 18±2% for the high-affinity state and the low-affinity state, respectively. The average percent of a1-adrenergic receptors binding NE with high affinity was significantly reduced (p<0.05) in animals with AMD pumps (12+9%) compared with animals with saline pumps (82±2%) (Figure 10 ). In one of three animals studied with AMD pumps, the agonist competition binding data were best fit to a single low-affinity site model with a KL of 880 ,uM, whereas a two-site model was preferred in the other two animals. The parameter estimates for the affinity constants were KH=2.4 xM and KL=60 ,uM. Na,K-ATPase As an index of the consistency of the membrane preparations, the membrane marker Na,K-ATPase was measured in aortic and mesenteric membrane preparations and was not found to be significantly different in the saline pump versus the AMD pump groups (Table 4) .
Catecholamine Levels
Baseline plasma NE levels in the AMD pump group were significantly increased (p<0.01) compared with values in the saline pump group (318±31 versus 198±9 pg/ml) 3-4 weeks after pump implantation. However, there were no differences in plasma epinephrine levels between the saline pump group and the AMD pump group.
Discussion
While most previous studies examining catecholamine desensitization have focused on the f-adrenergic receptor and the heart, peripheral vascular a1-adrenergic receptor desensitization has also been demonstrated.11-24 However, the mechanisms mediating desensitization have been examined primarily in acute or in vitro preparations. It is important to examine those mechanisms in a chronic, physiological preparation to understand more fully pathophysiological states with chronically elevated catecholamines or sympathetic tone. The current investigation is the first to study chronic a1-adrenergic desensitization in the conscious animal. In conscious dogs with reflex mechanisms intact but 8-adrenergic receptors blocked, a1-adrenergic receptor desensitization to the specific agonists, AMD, or PE was readily apparent.
a1-Adrenergic receptor desensitization was also demonstrated in vitro by examining dose-response relations in isolated vascular rings, and the cellular mechanisms of desensitization were explored in vascular smooth muscle membrane preparations. Interestingly, physiological desensitization to NE was more difficult to demonstrate. Desensitization to NE was observed only at the highest dose tolerated by the conscious dogs. However, after reflex mechanisms were eliminated, physiological desensitization to NE was clearly demonstrated. Thus, autonomic reflex and catecholamine uptake mechanisms effectively buffered responses to NE in the control state but were less effective after chronic ar-adrenergic receptor stimulation. Had the mechanisms been equally effective after chronic a1-adrenergic receptor stimulation, physiological desensitization to NE would have been readily apparent under all conditions; but because of the impairment in reflex and uptake control mechanisms, physiological desensitization was only apparent after these autonomic mechanisms were eliminated. Therefore, the different extent of physiological expression of desensitization observed under these conditions was due to different responses to acute NE challenges observed before AMD pump implantation. Several interlocking neural mechanisms appear to be responsible for the differences in the desensitization observed with different a-adrenergic receptor agonists. Since these studies were conducted in the presence of 13-adrenergic receptor blockade, complicating f8-adren- The NE-and PE-induced contractions were significantly attenuated in the amidephrine pump group compared with the saline pump group. preparations the a,-adrenergic receptor density does not differ, but the slope differs between the saline pump dog (o) and the amidephrine pump dog (A). In contrast, in membrane preparations from the mesentery, the slope is similar, but the arj-adrenergic receptor density differs between the saline pump dog (-) and the amidephrine pump dog (A). lation, reflex mechanisms, which include neuronal NE reuptake, mask the expression of physiological desensitization to an acute NE challenge.
In contrast to the NE responses, physiological desensitization was apparent with acute PE and AMD challenges even in the presence of only ,B-adrenergic receptor blockade. The desensitization was more apparent after addition of ganglionic blockade and further augmented after addition of NE-uptake blockade. One potential mechanism to explain this is that a1-adrenergic receptor agonists not only induce reflex buffering but also enhance the release of endogenous NE after chronic a1-adrenergic receptor stimulation. Thus, in the absence of AMD pumps, acute AMD challenges in the presence of J8-adrenergic receptor plus NE-uptake blockade induced greater increases in MAP and TPR compared with responses in the presence of /3-adrenergic receptor blockade, suggesting that the pressor and vasoconstrictor effects of AMD are due to both a direct action and to an indirect action involving release of endogenous NE.36-38 The indirect action of AMD may be due to its ability to induce carrier-mediated outward transport of NE. 39 In support of this postulate, plasma NE levels in the AMD pump group were higher than in the saline pump group.
It is important to note that the absolute increases in MAP and TPR induced by acute NE challenges after chronic a,-adrenergic receptor stimulation were similar, whether examined in the presence of ,3-adrenergic receptor blockade alone, when fl-blockade was combined with ganglionic blockade, or when it was combined with both ganglionic and NE-uptake blockade (Table 2) . However, the increases in MAP and TPR induced by acute NE challenges before chronic aradrenergic receptor stimulation increased progressively with addition of ganglionic and NE-uptake blockade, respectively. Therefore, the different extent of physiological desensitization observed under these conditions was due to different responses to acute NE challenges observed before AMD pump implantation. Thus, both reflex mechanisms in general and uptake mechanisms in particular were responsible for the abnormally low acutely into rabbits and examined this hyperadrenergic model for in vivo and in vitro evidence of desensitization. Their results also indicated that after an epinephrine infusion of 2 hours, a significant subsensitivity in the pressor response to PE is produced in conscious rabbits. In the corresponding in vitro experiments, they found a marked and prolonged loss in sensitivity of rabbit aortic rings to a-adrenergic receptor-mediated vascular contraction. 19 Recently, Hiremath et a124 found desensitization of a1-adrenergic receptor-induced vascular smooth muscle contraction both in the aortas from pheochromocytomabearing rats and also in aortic ring segments exposed for 6 hours in vitro to PE. In that study it was demonstrated that removal of the endothelium fully restored maximal responsiveness in both models, suggesting a major contribution of the endothelium in desensitization of a-adrenergic receptor-mediated smooth muscle contraction. 24 In contrast, in the present study there were no significant differences in the maximal contractile re There may be regional differences in the quantitative relation between the physiological responses of vascular smooth muscle and the number and affinity of its receptors, e.g., the dog thoracic aorta is known to have a large receptor reserve and many small arteries do not.42, 43 Thus, not only the reduction of receptors but also other agonist-induced alterations in coupling to second messengers may contribute to the mechanism of desensitization to a1-adrenergic receptor-mediated pressor and vasoconstrictor responses.
Another potential explanation for the separate mechanisms of a,-adrenergic receptor desensitization in vessels of different caliber is the possibility that NE concentration at the receptor in these vessels differs during chronic a1-adrenergic receptor stimulation. Chronic a1-adrenergic receptor stimulation may induce the release of endogenous catecholamines,36-38 a phenomenon that was also observed in this study. The concentration of whereas the uptake of NE is less in the mesenteric artery than the aorta.44 Furthermore, in the aorta the distance from the nerve ending to the vascular smooth muscle is relatively large, implying that the neurotransmitter NE would reach the vascular smooth muscle in lower concentrations.43 All these factors taken together could act to produce higher concentrations of NE at the receptor site in mesenteric vessels than the aorta and could explain why a,-adrenergic receptor downregulation occurs in mesenteric but not in aortic membranes. Finally, it is also possible to speculate that different a1-adrenergic receptor subtypes45'46 respond differently to chronic a,-adrenergic receptor stimulation.
In summary, chronic a,-adrenergic receptor stimulation results in physiological desensitization to selective a,-adrenergic receptor agonists and to the neurotransmitter NE in vitro. The in vitro studies did not demonstrate an important role for the endothelium in mediating desensitization. In the conscious animal, physiological desensitization to the neurotransmitter NE was more difficult to demonstrate, since it was masked by reflex mechanisms and neuronal uptake mechanisms that act to reduce the concentration of NE at the postjunctional receptor site. Thus, although endothelial mechanisms do not appear important, both autonomic reflex and biochemical mechanisms are altered by chronic a1-adrenergic receptor stimulation in the conscious dog; the altered autonomic mechanisms affect the physiological expression of desensitization, whereas separate biochemical mechanisms observed in vessels of different caliber mediate the desensitization. These complex mechanisms are important to consider in order to understand peripheral vascular control in pathophysiological states involving chronically elevated catecholamines or sympathetic tone.
